Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;24(6):1187-92.
doi: 10.1007/s00467-009-1130-0. Epub 2009 Feb 14.

Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome

Affiliations

Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome

Sarah J Swartz et al. Pediatr Nephrol. 2009 Jun.

Abstract

Immunoglobulin (Ig) M nephropathy is defined by electron-dense mesangial deposits and mesangial IgM visible by immunofluorescence (IF) without other histopathologic and immunofluorescent microscopic abnormalities. Certain patients have only immuno-positive (IgM+) IF. Children presenting with steroid-dependent or steroid-resistant nephrotic syndrome have a high prevalence of IgM+ IF with or without electron-dense deposits. We reviewed the clinical course of children with steroid-dependent or steroid-resistant nephrotic syndrome who underwent renal biopsy at Texas Children's Hospital from 1989 to 2006 to further characterize IgM+ IF in children with nephrotic syndrome. Of the 55 children with steroid-resistant or -dependent minimal change disease (MCD), 23 had IgM+ IF. Of these 23 children, 61% had microscopic hematuria at presentation, 48% (11/23) were steroid-dependent, and 48% (11/23) steroid-resistant (one underwent biopsy prior to steroid therapy). We compared the efficacy of adjuvant treatment with cyclophosphamide and cyclosporine: 18% initially treated with cyclophosphamide obtained remission, while 55% had no response; 83% obtained subsequent remission with cyclosporine. Of those initially treated with cyclosporine, 88% obtained complete or partial remission. IgM+ IF may be surrogate marker for the severity of MCD. Based on our results, children with MCD and IgM+ IF have a better response to cyclosporine than cyclophosphamide.

PubMed Disclaimer

References

    1. Clin Pediatr (Phila). 1988 Feb;27(2):63-8 - PubMed
    1. J Pediatr. 1994 Dec;125(6 Pt 1):981-6 - PubMed
    1. J Pediatr. 1981 Apr;98(4):561-4 - PubMed
    1. Pediatr Int. 2001 Jun;43(3):287-92 - PubMed
    1. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003594 - PubMed

MeSH terms

LinkOut - more resources